Global Next-Generation Sequencing Market Anticipated to Augment Owing to Increase In Healthcare Expenditure: Ken Research

Next-generation sequencing (NGS) is an enormously parallel sequencing technology that proposes ultra-high throughput, speed, and scalability. The technology is utilized to determine the order of nucleotides in whole genomes or targeted economies of DNS or RNA. NGS has transfigured has biological sciences, enabling labs to function a broad variety of applications and study the biological systems at a level never conceivable. In addition, NGS is progressively being integrated into clinical laboratory analysis, testing, and syndromes diagnostics in healthcare segments, globally. NGS has been extensively utilized in pharmacogenomics to quicken the drug discovery process.

NGS is of thrilling importance to medical practice as it delivers a definitive diagnosis for countless clinically heterogeneous syndromes. Consequently, it allows a more specific disease prognosis and delivers the guidance towards the selection of the greatest therapeutic choices for the affected patients. Much of its present promise comes from its ability to scrutinize the human genome at countless stages, from chromosome to single-base changes.

According to the report analysis, ‘Next-Generation Sequencing Market: Current Analysis and Forecast (2021-2027)’ states that the NGS market is increasing exponentially on account of augmenting the advancements in NGS technology, growing cancer incidences and augmenting the applications of NGS in countless sectors. Further, the study of genomics is fascinating attention from investors as well as from the public as it impacts the very core of lives and all living things across the globe.

Based on product/services, the market is segmented into consumables, platforms, services, and bioinformatics. The consumables sector generated revenue of USD XX million during 2020. The market is projected to augment at a CAGR of XX% throughout the forecast period to reach a market valuation of USD XX million by 2027F due to the growing demand of the reagents and several other consumables utilized for preparation of sample for sequencing of the genomes.

In addition, the growth of the global next generation sequencing market is majorly propelled by augment in genome mapping programs; growth in applications of next generation sequencing; augment in healthcare expenditure; and technological improvements in sequencing platforms. Moreover, the R&D connected to NGS has been escalating to new heights through higher investment in NGS technologies throughout the globe. Surge in requirement for genome mapping program and augment in application of NGS boom up the growth of the market.

North America is predicted to hold the greates share in the NGS market. The increasing focus of the foremost market players is on conveying the advanced, efficient NGS technologies to underdeveloped countries to cater to the requirement for genomic medicines and whole-genome sequencing for customized medicine. In addition, the growing implementation of NGS technology by the non-government and government bodies, along with augmented funding by the federal government and the private players, is predicted to propel the market growth. All these developments, along with the increasing healthcare expenditure and growing geographic footprints of the players, are propelling the growth of the market in the region.

For More Information, refer to below link:-

Global Next-Generation Sequencing Market

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249

Increasing Landscape Of The Global Next Generation Sequencing Market Outlook: Ken Research

According to the report analysis, ‘Global Next-Generation Sequencing (NGS) Market 2018-2024’ states that there are several key players which are presently functioning in this market more actively for leading the fastest market growth and attaining the highest market share across the globe in the short span of time by adopting the efficient strategies and policies of doing work and improving the specification of this which further being able to deliver beneficial information with the excess of new applications to the researchers for study the biological systems includes Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Oxford Nanopore Technologies Limited, Beijing Genomics Institute, Agilent Technologies, Inc., Qiagen N.V., Eurofins Scientific, F. Hoffmann-La Roche, DNASTAR, Inc., Biomatters Limited and other predominate and niche players. Moreover, the key players of this market are investing the huge amount of money in the research and development programs for developing the applications of this which further proved to be profitable for generating the high amount of revenue and leading the market growth more significantly in the short span of time with the high amount of market share around the globe.

The next-generation sequencing is abbreviated by NGS and is the enormously parallel sequencing technology that has developed the biological sciences. With its ultra-high throughput, speed and scalability, NGS allows the researcher to function a huge change of the applications and study the biological systems at a level never before possible. Furthermore, the key players of this market are playing an important role by doing effective developments and adoption of techniques of doing work while, the significant development in the technology is also taken place which provide better results to the researchers and proved to be beneficial for leading the fastest market growth in the coming years.

The Global Next-Generation Sequencing market is projected to observe a significant CAGR of 18.6% during the forecast period of 2018-2024.  Whereas, with the effective developments in the specification and working of the key players the market is spread across the globe more positively which proficiently includes North America, Europe, Asia Pacific, and Rest of the World (ROW). Meanwhile, the North America is the prominent shareholder in the global next-generation sequencing market, followed by Europe. Asia-Pacific region is anticipated to increase at high CAGR during the forecasted period owing to increasing funding for healthcare research, developing the patient pool, and rising healthcare expenditure. The markets in developing counties such as, India, China and Brazil are anticipated to rise at a rapid pace for next five years.

Presently, the next-generation sequencing market is associated with few key companies owing to the contribution of complicated technologies and the prerequisite of high capital investment. Sequencing based test may soon be viewed as the gold standard in the field of molecular diagnostics. The upsurge in the applications of NGS has made many biotechnological firms and diagnostic laboratories to invest profoundly in this field by introducing new products or attaining the other smaller firms or by partnership. Therefore, in the near future, it is expected that the market of next generation sequencing will increase across the globe more significantly over the recent few years.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/general-healthcare/next-generation-sequencing/173244-91.html

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249